Ref.: EFORL IR010/2020 9 March 2020 Subject: Notification of resolution of Board of Director meeting, schedule of the 2020 Annual General Meeting of Shareholder, Dividend Omission and Acquisition and
million or 10.3%(y-o-y) , representing Net profit margin of 26.9% and 27.5% respectively. Thus have earnings per share of Bt0.40 and Bt1.22. In Q3/2019 and the nine months of 2019, the Group has been
, Assets . . . .% Liabilities . . (.) (.%) Shareholders' equity . . . .% Issued and fully paid-up common share (Million Share) . . . .% Par (Baht) . . . .% . Assets Overall asset in the six months of
28.3% compared to 31.6% which has an earnings per share of Bt1.52. However, excluding the special items for 2016, net profit attributable to equity holders of the Company will decrease by Bt 65.4 million
be a potential market in the future. For Medical Devices; There is still intense competition in both domestic and foreign markets. Market leaders use price strategies to gain market share. But the
Liabilities 3,401 3,450 -1% Authorized share capital 140 140 +0% Issued and fully paid-up share capital 140 140 +0% Share premium 6 6 -0.0% Retained earnings 866 908 -4.6% Other components of equity 196 189 +4
% Authorized share capital 140 140 +0% Issued and fully paid-up share capital 140 140 +0% Share premium 6 6 -0.0% Retained earnings 866 908 -4.6% Other components of equity 196 189 +4% Deduct: Treasury stock
which decreasing by Bt66.2 million or -27.3%(y-o-y) and of Bt40.9 million or -7.2%(y-o-y), representing Net profit margin of 19.2% and 27.8% respectively. Thus have earnings per share of Bt0.28 and Bt0.82
positively on cash for the rest of 2019. There was a dividend payment of 1Q 2019 of 0.12THB/share or 36mTHB total. Quarterly dividends are planned to be maintained at this level for 2019 dependent on results
34.2% and 32.6% respectively. The earnings per share of Q3/2018 and the nine months of 2018 were Bt0.48 and Bt1.36. Table summarized the operating results of the Group (unit : Bt million) Page 3 of 7 1.1